Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
about
Management of lymphangioleiomyomatosisUnderstanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Antibodies to Type IV Collagen Induce Type 1 Autoimmune Pancreatitis.
P2860
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@ast
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@en
type
label
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@ast
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@en
prefLabel
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@ast
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@en
P2093
P2860
P1476
Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV
@en
P2093
Brian Gregory Oliver
Caroline Akemi Heckman
Janette Kay Burgess
Judith Lee Black
Lyn Margaret Moir
Markus Weckmann
P2860
P304
P356
10.1111/J.1582-4934.2012.01648.X
P577
2012-12-01T00:00:00Z